Suppression of ANP gene transcription by liganded vitamin D receptor: Involvement of specific receptor domains

Songcang Chen, Jianming Wu, Jui Cheng Hsieh, G. Kerr Whitfield, Peter Jurutka, Mark R. Haussler, David G. Gardner

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We showed previously that liganded vitamin D receptor (VDR) effects a suppression of human atrial natriuretic peptide (hANP) gene-promoter activity in cultured neonatal rat atrial myocytes. In the present study, we have attempted to identify the structural domains of the VDR that are involved in mediating this suppression. We examined the effects of a series of VDR mutants on a cotransfected hANP promoter-driven chloramphenicol acetyltransferase (CAT) reporter. Neither the native VDR nor any of the mutants tested displayed inhibitory activity in the absence of the 1,25- dihydroxyvitamin D3 (VD3) ligand. Δ134, a deletant harboring solely the DNA binding region of the VDR, and L254G, a mutant shown to be defective in retinoid X receptor (RXR) heterodimer formation in other systems, were as effective as the native VDR in reducing promoter activity. HBD, a deletant containing only the hormone-binding domain of the VDR, and K246G, a point mutant that is defective in the activation function of the receptor, did not attenuate reporter activity. A similar activity profile was displayed when a positively regulated promoter containing a direct-repeat vitamin D responsive element (DR3-CAT) was examined in these cells. Liganded VDR, the Δ134 mutant, and liganded L254G effected increases in DR3-CAT activity of 2.5-, 2- , and 4-fold, respectively. Two nonhypercalcemic analogues of VD3 (RO 23- 7553 and RO 25-6760) displayed the same inhibitory activity as VD3. These studies suggest that the inhibition of hANP promoter activity requires both the DNA binding and activation functions of the receptor but does not appear to require formation of a classic RXRα-VDR heterodimer.

Original languageEnglish (US)
Pages (from-to)1338-1342
Number of pages5
JournalHypertension
Volume31
Issue number6
StatePublished - Jun 1998

Fingerprint

Calcitriol Receptors
Atrial Natriuretic Factor
Genes
Chloramphenicol O-Acetyltransferase
Retinoid X Receptors
Calcitriol
Nucleic Acid Repetitive Sequences
DNA
Vitamin D
Muscle Cells
Hormones
Ligands

Keywords

  • Peptides
  • Transcription, genetic
  • Vitamin D receptor mutants
  • Vitamin D

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Chen, S., Wu, J., Hsieh, J. C., Whitfield, G. K., Jurutka, P., Haussler, M. R., & Gardner, D. G. (1998). Suppression of ANP gene transcription by liganded vitamin D receptor: Involvement of specific receptor domains. Hypertension, 31(6), 1338-1342.

Suppression of ANP gene transcription by liganded vitamin D receptor : Involvement of specific receptor domains. / Chen, Songcang; Wu, Jianming; Hsieh, Jui Cheng; Whitfield, G. Kerr; Jurutka, Peter; Haussler, Mark R.; Gardner, David G.

In: Hypertension, Vol. 31, No. 6, 06.1998, p. 1338-1342.

Research output: Contribution to journalArticle

Chen, S, Wu, J, Hsieh, JC, Whitfield, GK, Jurutka, P, Haussler, MR & Gardner, DG 1998, 'Suppression of ANP gene transcription by liganded vitamin D receptor: Involvement of specific receptor domains', Hypertension, vol. 31, no. 6, pp. 1338-1342.
Chen, Songcang ; Wu, Jianming ; Hsieh, Jui Cheng ; Whitfield, G. Kerr ; Jurutka, Peter ; Haussler, Mark R. ; Gardner, David G. / Suppression of ANP gene transcription by liganded vitamin D receptor : Involvement of specific receptor domains. In: Hypertension. 1998 ; Vol. 31, No. 6. pp. 1338-1342.
@article{263292329f35473f801d4129ac7e73db,
title = "Suppression of ANP gene transcription by liganded vitamin D receptor: Involvement of specific receptor domains",
abstract = "We showed previously that liganded vitamin D receptor (VDR) effects a suppression of human atrial natriuretic peptide (hANP) gene-promoter activity in cultured neonatal rat atrial myocytes. In the present study, we have attempted to identify the structural domains of the VDR that are involved in mediating this suppression. We examined the effects of a series of VDR mutants on a cotransfected hANP promoter-driven chloramphenicol acetyltransferase (CAT) reporter. Neither the native VDR nor any of the mutants tested displayed inhibitory activity in the absence of the 1,25- dihydroxyvitamin D3 (VD3) ligand. Δ134, a deletant harboring solely the DNA binding region of the VDR, and L254G, a mutant shown to be defective in retinoid X receptor (RXR) heterodimer formation in other systems, were as effective as the native VDR in reducing promoter activity. HBD, a deletant containing only the hormone-binding domain of the VDR, and K246G, a point mutant that is defective in the activation function of the receptor, did not attenuate reporter activity. A similar activity profile was displayed when a positively regulated promoter containing a direct-repeat vitamin D responsive element (DR3-CAT) was examined in these cells. Liganded VDR, the Δ134 mutant, and liganded L254G effected increases in DR3-CAT activity of 2.5-, 2- , and 4-fold, respectively. Two nonhypercalcemic analogues of VD3 (RO 23- 7553 and RO 25-6760) displayed the same inhibitory activity as VD3. These studies suggest that the inhibition of hANP promoter activity requires both the DNA binding and activation functions of the receptor but does not appear to require formation of a classic RXRα-VDR heterodimer.",
keywords = "Peptides, Transcription, genetic, Vitamin D receptor mutants, Vitamin D",
author = "Songcang Chen and Jianming Wu and Hsieh, {Jui Cheng} and Whitfield, {G. Kerr} and Peter Jurutka and Haussler, {Mark R.} and Gardner, {David G.}",
year = "1998",
month = "6",
language = "English (US)",
volume = "31",
pages = "1338--1342",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Suppression of ANP gene transcription by liganded vitamin D receptor

T2 - Involvement of specific receptor domains

AU - Chen, Songcang

AU - Wu, Jianming

AU - Hsieh, Jui Cheng

AU - Whitfield, G. Kerr

AU - Jurutka, Peter

AU - Haussler, Mark R.

AU - Gardner, David G.

PY - 1998/6

Y1 - 1998/6

N2 - We showed previously that liganded vitamin D receptor (VDR) effects a suppression of human atrial natriuretic peptide (hANP) gene-promoter activity in cultured neonatal rat atrial myocytes. In the present study, we have attempted to identify the structural domains of the VDR that are involved in mediating this suppression. We examined the effects of a series of VDR mutants on a cotransfected hANP promoter-driven chloramphenicol acetyltransferase (CAT) reporter. Neither the native VDR nor any of the mutants tested displayed inhibitory activity in the absence of the 1,25- dihydroxyvitamin D3 (VD3) ligand. Δ134, a deletant harboring solely the DNA binding region of the VDR, and L254G, a mutant shown to be defective in retinoid X receptor (RXR) heterodimer formation in other systems, were as effective as the native VDR in reducing promoter activity. HBD, a deletant containing only the hormone-binding domain of the VDR, and K246G, a point mutant that is defective in the activation function of the receptor, did not attenuate reporter activity. A similar activity profile was displayed when a positively regulated promoter containing a direct-repeat vitamin D responsive element (DR3-CAT) was examined in these cells. Liganded VDR, the Δ134 mutant, and liganded L254G effected increases in DR3-CAT activity of 2.5-, 2- , and 4-fold, respectively. Two nonhypercalcemic analogues of VD3 (RO 23- 7553 and RO 25-6760) displayed the same inhibitory activity as VD3. These studies suggest that the inhibition of hANP promoter activity requires both the DNA binding and activation functions of the receptor but does not appear to require formation of a classic RXRα-VDR heterodimer.

AB - We showed previously that liganded vitamin D receptor (VDR) effects a suppression of human atrial natriuretic peptide (hANP) gene-promoter activity in cultured neonatal rat atrial myocytes. In the present study, we have attempted to identify the structural domains of the VDR that are involved in mediating this suppression. We examined the effects of a series of VDR mutants on a cotransfected hANP promoter-driven chloramphenicol acetyltransferase (CAT) reporter. Neither the native VDR nor any of the mutants tested displayed inhibitory activity in the absence of the 1,25- dihydroxyvitamin D3 (VD3) ligand. Δ134, a deletant harboring solely the DNA binding region of the VDR, and L254G, a mutant shown to be defective in retinoid X receptor (RXR) heterodimer formation in other systems, were as effective as the native VDR in reducing promoter activity. HBD, a deletant containing only the hormone-binding domain of the VDR, and K246G, a point mutant that is defective in the activation function of the receptor, did not attenuate reporter activity. A similar activity profile was displayed when a positively regulated promoter containing a direct-repeat vitamin D responsive element (DR3-CAT) was examined in these cells. Liganded VDR, the Δ134 mutant, and liganded L254G effected increases in DR3-CAT activity of 2.5-, 2- , and 4-fold, respectively. Two nonhypercalcemic analogues of VD3 (RO 23- 7553 and RO 25-6760) displayed the same inhibitory activity as VD3. These studies suggest that the inhibition of hANP promoter activity requires both the DNA binding and activation functions of the receptor but does not appear to require formation of a classic RXRα-VDR heterodimer.

KW - Peptides

KW - Transcription, genetic

KW - Vitamin D receptor mutants

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=0031810660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031810660&partnerID=8YFLogxK

M3 - Article

C2 - 9622151

AN - SCOPUS:0031810660

VL - 31

SP - 1338

EP - 1342

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -